Emergency’s scoring systems Model (min-max) Temp (°C) SBP (mmHg) MAP (mm Hg) RR (BPM) Pulse (BMP) GCS AVPU O2 sat (%) Age (year) WPS (0-14) ≥35.3; 0 <35.3; 3 ≥100; 0 ≤99; 2 NA ≤19; 0 20-21; 1 ≥22; 2 ≤101; 0 ≥102; 1 NA A; 0 Other; 3 96-100; 0 94-95; 1 92-93; 2 <92; 3 NA REMS (0-26) NA NA 70-109; 0 50-69; 2 110-129; 2 130-159; 3 ≤49; 4 ≥160; 4 12-24; 0 10-11; 1 25-34; 1 6-9; 2 35-49; 3 ≤5; 4 ≥50; 4 70-109; 0 50-69; 2 110-139; 2 40-54; 3 140-179; 3 ≤39; 4 ≥180; 4 ≥14; 0 11-13; 1 8-10; 2 5-7; 3 ≤4; 4 NA >89; 0 86-89; 1 75-85; 3 <75; 4 <45; 0 45-54; 2 55-64; 3 65-73; 5 ≥74; 6 MEWS (0-19) ≤35; 2 35-38.4; 0 ≥38.5; 2 ≤70; 3 71-80; 2 81-100; 1 101-199; 0 ≥200; 3 NA <9; 2 9-14; 0 15-20; 1 21-29; 2 ≥30; 3 <40; 2 41-50; 1 51-100; 0 101-110; 1 111-129; 2 ≥130; 3 NA Alert; 0 React to voice; 1 React to pain; 2 Unresponsive; 3 NA NA ICU’s scoring systems Model (min-max) Temp (°C) MAP (mmHg) Pulse (BPM) RR (BPM) Oxygenation (paO2 /FiO2 ) GCS HCO3 (mmHg) K (mmol/L) Na (mmol/L) Cr (mg/dL) HCT (%) TLC (%) pH Age (year) APACHE II (0-71) ≥41; 4 39-40.9; 3 38.5-38.9; 1 36-38.4; 0 34-35.9; 1 32-33.9; 2 30-31.9; 3 ≤29.9; 4 ≥160; 4 130-159; 3 110-129; 2 70-109; 0 50-69; 2 ≤49; 4 ≥100; 4 140-179; 3 110-139; 2 70-109; 0 50-69; 2 40-54; 3 ≤39; 4 ≥50; 4 35-49; 3 25-34; 1 12-24; 0 10-11; 1 6-9; 2 ≤5; 4 ≥500; 4 350-499; 3 200-349; 2 <200 & PO2 >70; 0 PO2 61-70; 1 PO2 55-60; 3 PO2 <55; 4 15-GCS ≥52; 4 41-51.9; 3 32-40.9; 1 22-31.9; 0 18-21.9; 2 15-17.9; 3 <15; 4 ≥7; 4 6-6.9; 3 5.5-5.9; 1 3.5-5.4; 0 3-3.4; 1 2.5-2.9; 2 <2.5; 4 ≥100; 4 160-179; 3 155-159; 2 150-154; 1 130-149; 0 120-129; 2 111-119; 3 ≤110; 4 ≥3.5; 4 2-3.4; 3 1.5-1.9; 2 0.6-1.4; 0 <0.6; 2 ≥60; 4 50-59.9; 2 46-49.9; 1 30.45.9; 0 20-29.9; 2 <20; 4 ≥40; 4 20-39.9; 2 15-19.9; 1 3-14.9; 0 1-2.9; 2 <1; 4 7.7; 4 7.6-7.69; 3 7.5-7.59; 1 7.33-7.49; 0 7.25-7.32; 2 7.15-7.24; 3 <7.15; 4 <44; 0 45-54; 2 55-64; 3 65-74; 5 ≥75; 6 Model (min-max) Temp (°C) MAP (mmHg) Pulse (BPM) UO (mL/h) Oxygenation paO2 /FiO2 GCS HCO3 (mmHg) K (mmol/L) Na (mmol/L) Bili (mg/dL) Chronic disease TLC (%) Urea (mg/dL) Age (year) SAPS II <39; 0 >39; 3 <70; 13 70-99; 5 100-199; 0 >200; 2 <40; 11 40-69; 2 70-119; 0 120-159; 4 >160; 7 <500; 11 >500; 4 >1000; 0 <100; 11 100-199; 9 >200; 6 <6; 26 6-8; 13 9-10; 7 11-13; 5 14-15; 0 <15; 6 15-19; 3 >20; 0 <3; 3 3-4.9; 0 >5; 3 <125; 5 125-144; 0 >145; 1 <4; 0 4-5.9; 4 >6; 9 M.Cancer; 9 HemMalig; 10 AIDS; 17 <1; 12 1-20; 0 >20; 3 <28; 0 28-83; 6 >84; 10 <40; 0 40-59; 7 60-69; 12 70-74; 15 75-79; 16 ≥80; 8 MAP (mmHg) Oxygenation (paO2/FiO2 ) GCS Bili (mg/dL) Cr (mg/dL) Platelets (10 9 /L) SOFA ≥70; 0 <70; 1 or Dob; 2 Dop 5.1-15 or ; 3 or or ; 4 ≥400; 0 <400; 1 <300; 2 <200+ RS; 3 <100+ RS; 4 15; 0 13-14; 1 10-12; 2 6-9; 3 <6; 4 <1.2; 0 1.2-1.9; 1 2-5.9; 2 6-11.9; 3 >12; 4 <1.2; 0 1.2-1.9; 1 2-3.4; 2 3.5-4.9; 3 >5; 4 ≥150; 0 <150; 1 <100; 2 <50; 3 <20; 4